These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 2966209

  • 21. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [Abstract] [Full Text] [Related]

  • 22. T cell receptor/CD3 complex internalization following activation of a cytolytic T cell clone: evidence for a protein kinase C-independent staurosporine-sensitive step.
    Boyer C, Auphan N, Luton F, Malburet JM, Barad M, Bizozzero JP, Reggio H, Schmitt-Verhulst AM.
    Eur J Immunol; 1991 Jul; 21(7):1623-34. PubMed ID: 1829410
    [Abstract] [Full Text] [Related]

  • 23. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
    Zhu HG, Klein-Franke A, Anderer FA.
    Anticancer Res; 1994 Jul; 14(3A):953-61. PubMed ID: 8074498
    [Abstract] [Full Text] [Related]

  • 24. Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.
    Oshima S, Eckels DD.
    J Immunol; 1990 Dec 15; 145(12):4018-25. PubMed ID: 1979584
    [Abstract] [Full Text] [Related]

  • 25. MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells.
    Fisch P, Oettel K, Fudim N, Surfus JE, Malkovsky M, Sondel PM.
    J Immunol; 1992 Apr 15; 148(8):2315-23. PubMed ID: 1532810
    [Abstract] [Full Text] [Related]

  • 26. DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line.
    Takahashi S, Maecker HT, Levy R.
    Eur J Immunol; 1989 Oct 15; 19(10):1911-9. PubMed ID: 2531090
    [Abstract] [Full Text] [Related]

  • 27. Detection of function-associated molecules on rat leukemic NK cells: activation by monoclonal antibody or phorbol ester.
    Evans DL, Harris DT, Staton DL, Jaso-Friedmann L.
    Nat Immun Cell Growth Regul; 1990 Oct 15; 9(6):353-65. PubMed ID: 2087244
    [Abstract] [Full Text] [Related]

  • 28. Requirements for triggering of lysis by cytolytic T lymphocyte clones.
    Lancki DW, Weiss A, Fitch FW.
    J Immunol; 1987 Jun 01; 138(11):3646-53. PubMed ID: 2953785
    [Abstract] [Full Text] [Related]

  • 29. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS, Schoon RA, Leibson PJ.
    J Immunol; 1993 Feb 15; 150(4):1429-36. PubMed ID: 8432986
    [Abstract] [Full Text] [Related]

  • 30. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
    Geppert TD, Lipsky PE.
    J Immunol; 1986 Nov 15; 137(10):3065-73. PubMed ID: 3095421
    [Abstract] [Full Text] [Related]

  • 31. Induction of nonspecific cytotoxicity by monoclonal anti-T3 antibodies.
    Leeuwenberg JF, Spits H, Tax WJ, Capel PJ.
    J Immunol; 1985 Jun 15; 134(6):3770-5. PubMed ID: 2580895
    [Abstract] [Full Text] [Related]

  • 32. CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.
    Starling GC, Hart DN.
    Immunology; 1990 Oct 15; 71(2):190-5. PubMed ID: 2146214
    [Abstract] [Full Text] [Related]

  • 33. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM, Zhu HG, Anderer FA.
    Anticancer Res; 1993 Oct 15; 13(4):923-30. PubMed ID: 8352560
    [Abstract] [Full Text] [Related]

  • 34. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA, June CH, Martin PJ, Spooner CE, Hansen JA, Meier KE.
    J Immunol; 1986 Jun 01; 136(11):3945-52. PubMed ID: 3084650
    [Abstract] [Full Text] [Related]

  • 35. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
    Nakamura T, Takahashi K, Fukazawa T, Koyanagi M, Yokoyama A, Kato H, Yagita H, Okumura K.
    J Immunol; 1990 Dec 01; 145(11):3628-34. PubMed ID: 1700989
    [Abstract] [Full Text] [Related]

  • 36. Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only.
    Goedegebuure PS, Segal DM, Braakman E, Vreugdenhil RJ, Van Krimpen BA, Van de Griend RJ, Bolhuis RL.
    J Immunol; 1989 Mar 15; 142(6):1797-802. PubMed ID: 2466076
    [Abstract] [Full Text] [Related]

  • 37. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules.
    Poggi A, Pardi R, Pella N, Morelli L, Sivori S, Vitale M, Revello V, Moretta A, Moretta L.
    Eur J Immunol; 1993 Oct 15; 23(10):2454-63. PubMed ID: 8405045
    [Abstract] [Full Text] [Related]

  • 38. Cytotoxic T lymphocyte unresponsiveness induced by prolonged treatment with immobilized anti-CD3 antibody. Association of impairment of cytolytic activity with temporary depletion of intracellular protein kinase C.
    Sano S, Kiyotaki C, Tatsumi Y, Fujiwara H, Hamaoka T.
    J Immunol; 1989 Nov 01; 143(9):2797-805. PubMed ID: 2530277
    [Abstract] [Full Text] [Related]

  • 39. Activation of human T lymphocytes. III. Triggering of bystander cytotoxicity in cytotoxic T cell clones by antibodies against the T3 antigen or by a calcium ionophore.
    Schrezenmeier H, Kurrle R, Wagner H, Fleischer B.
    Eur J Immunol; 1985 Oct 01; 15(10):1019-24. PubMed ID: 3932080
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC, Davidson SE, Nimmo JC, Beard ME, Hart DN.
    Clin Exp Immunol; 1989 Dec 01; 78(3):396-401. PubMed ID: 2532991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.